Skip to main content

Pharma stocks crater as investors brace for billions in heartburn drug litigation charges

For many investors and analysts, this ordeal brings back memories of the Bayer Roundup saga.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.